GNC Holdings Inc (GNC)

neg -0.23
Today's Range: 29.73 - 30.43 | GNC Avg Daily Volume: 2,551,600
Last Update: 11/30/15 - 2:15 PM EST
Volume: 533,204
YTD Performance: -36.01%
Open: $30.25
Previous Close: $30.05
52 Week Range: $22.64 - $51.69
Oustanding Shares: 82,653,778
Market Cap: 2,494,491,020
6-Month Chart
TheStreet Ratings Grade for GNC
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 2 3 4 4
Moderate Buy 1 1 1 1
Hold 7 6 5 5
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.45 2.25 2.05 2.05
Latest Dividend: 0.18
Latest Dividend Yield: 2.39%
Dividend Ex-Date: 12/09/15
Price Earnings Ratio: 11.48
Price Earnings Comparisons:
GNC Sector Avg. S&P 500
11.48 11.50 32.68
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-34.65% -31.98% -12.65%
Revenue -0.70 0.26 0.08
Net Income -3.50 0.93 0.24
EPS 3.40 1.23 0.30
Earnings for GNC:
Revenue 2.61B
Average Earnings Estimates
Qtr (12/15) Qtr (03/16) FY (12/15) FY (12/16)
Average Estimate $0.59 $0.83 $2.88 $3.18
Number of Analysts 7 4 9 9
High Estimate $0.60 $0.92 $2.90 $3.45
Low Estimate $0.57 $0.78 $2.85 $3.10
Prior Year $0.61 $0.75 $2.87 $2.88
Growth Rate (Year over Year) -3.75% 11.00% 0.39% 10.30%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Stand-alone vitamin and supplement shops like GNC and Vitamin Shoppe shares will continue to fall in light of a Justice Department investigation.
The next wave of retail earnings is upon us, and they are arguably worse than the first round.
Oct 23, 2015 | 7:18 AM EDT
GNC was downgraded from Buy to Neutral, Sterne Agee CRT said. $38 price target. AG lawsuit adds risk to the model. 

GNC Takes a Hit Real Money Pro($)

GNC Holdings (GNC) is down by 12% today as a lawsuit claims the company violated Oregon Unlawful Trade Practices Act by "misrepresenting certain products as lawful dietary supplements when they actually are unapproved drugs that may not be lawfully sold in the U.S. as a dietary supplement."
Mar 12, 2015 | 7:47 AM EDT
GNC was upgraded from Equal-weight to Overweight, Morgan Stanley said. $56 price target. Stock is down on regulatory risks, but expect ...
Nov 07, 2014 | 8:39 AM EST
GNC upgraded to Buy from Neutral, said Goldman Sachs. Price target raised to $49 from $44 as confidence in turnaround effort firms.&nbs...
Market action could get a bumpy after last week's big move.
Sep 17, 2014 | 8:05 AM EDT
GNC was upgraded from Neutral to Outperform, Wedbush said. $46 price target. Company has reduced promotions and faces easier near-term ...
We'll be watching for signs of Ukraine fallout over the weekend.
Aug 11, 2014 | 8:14 AM EDT
GNC was upgraded from Neutral to Outperform, Credit Suisse said. $43 price target. Valuation call, as the company has strong management...

Columnist Conversations

Let's notice that Apple Inc. (AAPL) has been levitating and consolidating above its 200-Day EMA (116.79) for t...
We continue to be upbeat about select healthcare for the upcoming 3 to 12 months. We like select Biotech/Pharm...
Market continues to be slightly down at midday. Biotech taking a big hit today with the major indices down mo...
If I'm reading the argument correctly, because other governments want to take their taxpayers' money and redir...


News Breaks

Powered by


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.